Doha, Qatar: Carnegie Mellon University in Qatar (CMU-Q) and QLife Pharma signed a Memorandum of Understanding (MoU) to cooperate in the areas of research, education, and the career development of Carnegie Mellon students.
During the ceremony, Dr. Ahmed Hamad Al Mohanadi, CEO of QLife Pharma, commented: “It is very important that Qatar achieves self-sufficiency in medicine, and that is part of our organization’s main objective. We aim to provide high-quality, affordable medication, while serving both the local and global community. Such goals can only be accomplished through collaborations with research and development institutions, which is why our partnership with CMU-Q is such an exciting opportunity.”
QLife Pharma is dedicated to the manufacturing of high-quality products using world class advanced technology. The first pharmaceutical company in Qatar, QLife Pharma aims to be a premier, research-intensive pharmaceutical company dedicated to providing leading innovations and solutions.
Michael Trick, the dean of CMU-Q, added: “The strategic partnership with QLife Pharma is an important one for CMU-Q, particularly for our Biological Sciences Program. Our students develop very strong laboratory skills beginning in their first semester and exposure to the pharmaceutical industry will serve to broaden their experience and open new career possibilities. ”
Gordon Rule, area head of the Biological Sciences Program at CMU-Q, noted, “We train our students to solve real world problems, which is what makes our partnership with QLife Pharma so important. We can equip our students with the foundation knowledge of how to operate in the industry, but to have access to the industry itself is a first and a wonderful opportunity.”
Carnegie Mellon University in Qatar delivers select programs that contribute to the long-term development of Qatar. Approximately 400 students from 38 countries study at CMU-Q in the areas of biological sciences, business administration, computational biology, computer science, and information systems.